ABSTRACT
La inercia clínica se define como los fallos del médico en el inicio o la intensificación del tratamiento cuando están indicados. Nuestro objetivo es reflexionar sobre este concepto aplicado en enfermedad pulmonar obstructiva crónica y asma, y el papel del profesional sanitario y del sistema de salud como actores implicados. Dejamos aparte la inercia del paciente para otro ámbito de estudio e intervención. Proponemos definir la inercia clínica para procesos durante el diagnóstico y el tratamiento cuando no se inicia o modifica (intensifica o disminuye) una terapia. También se identifican los factores que contribuyen a la inercia clínica o terapéutica y se plantean estrategias de mejora. (AU)
Clinical inertia is defined as the physicians failure to initiate or intensify treatment when it is indicated. Our objective is to reflect on this concept applied to chronic obstructive pulmonary disease and asthma, and the role of health professional and health system as stakeholders. We leave patient inertia aside for another area of study and intervention. We propose to define clinical inertia for diagnosis and therapeutic processes when a treatment is not started or modified (intensifies or decreases). Factors that contribute to clinical and/or therapeutic inertia are also identified and improvement strategies are proposed. (AU)
Subject(s)
Humans , Pulmonary Disease, Chronic Obstructive , Asthma , Clinical Competence/standards , Pulmonary Medicine , Professional RoleSubject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Autoimmune Diseases , Immunoglobulin G4-Related Disease , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Hemorrhage/etiology , HumansABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Vasculitis , Immunoglobulin G4-Related Disease , Undifferentiated Connective Tissue Diseases , Immunoglobulin G4-Related Disease/diagnostic imagingABSTRACT
No disponible
